Mass spectrometry, a powerful tool for studying tiny molecules, has long helped scientists unlock secrets hidden in plants, ...

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform ...

Malaria remains a persistent public health burden, with Plasmodium falciparum causing the most dangerous form of malaria and ...

Zilliz, creator of the world's most widely adopted open-source vector database, Milvus, introduced a powerful new set of Migration Services designed to make moving unstructured data and vector ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...

The global Phenylketonuria (PKU) Treatment is undergoing a strategic transformation, driven by novel drug candidates and a more targeted understanding of unmet clinical needs. With a global prevalence ...

Telangana government to monitor COVID-19 mutations through genome sequencing, prepares for seasonal disease surge with ...

This fundamental study combines in vitro reconstitution experiments and molecular dynamics simulations to elucidate how membrane lipids are transported from the outer to the inner membrane of ...